ARTICLE | Clinical News
Darapladib: Phase III start
May 5, 2008 7:00 AM UTC
GlaxoSmithKline plans to start a Phase III trial of oral darapladib. The company discovered darapladib based on Human Genome’s technology under a 1993 deal. Human Genome has an option to co-promote da...